pTau-217 Assay
The Quanterix Simoa® ALZpath p-Tau 217 Assay provides an ultrasensitive, reliable solution for detecting phosphorylated Tau 217 (p-Tau 217) in blood. This critical biomarker is essential for Alzheimer’s research, offering insights into disease progression and helping differentiate Alzheimer’s from other forms of dementia.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Phosphorylation at the threonine 217 site in tau protein, known as p-Tau 217, is a critical biomarker in Alzheimer’s disease research. Elevated levels of p-Tau 217 in blood have been observed in Alzheimer’s patients, even during early stages, indicating its potential for early detection. Furthermore, studies show that p-Tau 217 helps differentiate Alzheimer’s disease from other forms of dementia, such as Lewy body dementia and frontotemporal dementia, making it a valuable diagnostic tool.
Simoa Technology aims to transform future Alzheimer's disease detection and treatment
Learn how biomarkers can be used to transform drug approval and patient management in neurodegenerative medicine
